Interleukin 7 is produced by murine and human keratinocytes by unknown
Brief Delinitive Report 
Interleukin  7  Is Produced  by Murine  and Human 
Keratinocytes 
By Christine Heufler, Gerda Topar, Alfred Grasseger, Ursula Stanzl, 
Franz Koch, Nikolaus Romani, Anthony E. Namen,* and 
Gerold Schuler 
From the Department of Dermatology, University of Innsbruck, A-6020 Innsbruck, Austria; 
and "Immunex Corporation, Seattle, Washington 98101 
Summary 
Interleukin 7  (IL-7) was originally identified as a growth factor for B  cell progenitors,  and 
subsequently has been shown to exert proliferative effects on T cell progenitors and mature peripheral 
T cells as well. Constitutive IL-7 mKNA expression so far had been demonstrated in bone marrow 
stromal cell lines,  thymus, spleen, and among nonlymphoid tissues  in liver and kidney. Here 
we show that both murine and human keratinocytes express IL-7 mRNA and release IL-7 protein 
in biologically relevant amounts.  The physiological or pathological relevance of keratinocyte- 
derived IL-7 is presently unknown. Our finding that keratinocytes can produce IL-7 in concert 
with reports that IL-7 is a growth factor for in vivo primed antigen-specific T  cells,  as well 
as for T  lymphoma cells suggests, however,  that keratinocyte-derived IL-7 is important in the 
pathogenesis of inflammatory skin diseases and cutaneous T  cell lymphoma. 
I 
L-7 was originally detected and isolated as a bone marrow 
stromal cell line-derived cytokine supporting the growth 
of B cell precursors (1, 2). Northern blotting analysis of var- 
ious BALB/c tissues demonstrated that besides bone marrow 
stromal cells, IL-7 mRNA is constitutively expressed in liver, 
kidney, spleen, and, remarkably, also in thymic tissue (2), 
indicating a potential role for IL-7 in T  cell development. 
Indeed, IL-7 was then shown to stimulate the growth of T 
cell progenitors as well (for a review see reference 3), thus 
emerging as a major regulator of early B and T cell develop- 
ment. More recently it has become evident that under cer- 
tain conditions IL-7 can also stimulate the growth of mature 
peripheral T cells and T clones (4-8). This finding prompted 
us to follow up our incidental observation that murine ker- 
atinocytes seem to express IL-7 mRNA when studied by RT- 
PCR analysis (9).  Here we demonstrate that both routine 
and human keratinocytes express IL-7 mRNA and release IL-7 
protein.  Our findings suggest a pathogenetic role of kera- 
tinocyte-derived IL-7 in inflammatory skin diseases, as well 
as cutaneous T cell lymphoma as antigen-specific T cells primed 
in vivo (5) and T lymphoma cells (10-13)  have been shown 
to readily proliferate in response to IL-7. 
Materials and Methods 
Preparation of Murine Epidermal Cells and Keratinocytes.  Specific 
pathogen-free BALB/c (H-2  a) mice (6-12-wk-old of both sexes) 
were obtained from Charles River Wiga GmbH (Sulzfeld, Ger- 
many). Epidermal cell (EC) suspensions were prepared from ear 
skin and treated with anti-Thyl-mAb (culture supernatant from 
clone 13.4, mouse IgM, TIB 99 from the American Type Culture 
Collection [ATCC], Rockville, MD) and rabbit C' exactly as de- 
scribed (14), except that we included anti-I-A  b,d mAb  (clone B 
21-2, rat IgG2b, TIB 229 from the ATCC) in most experiments 
to  remove not  only the  Thy  1"  TCR-T//~ bearing dendritic 
epidermal T cells (15), but also the Ia+ epidermal  Langerhans  cells. 
For further depletion, the resulting EC suspensions were then in- 
cubated with anti-I-E  k,d (clone 14-4-4S, mouse IgG2a, HB32) as 
described (16) and anti-CD45 (clone M 1/9, rat IgG2, TIB 122 
from the ATCC) mAbs, and then panned on petri dishes coated 
with nonspecies specific goat anti-mouse Ig exactly as described 
(14). The nonadherent cell fractions constituted virtually pure ker- 
atinocytes as evidenced by morphology and immunofluorescent 
staining of cytocentrifuge preparations with rabbit anti-cow ker- 
atin Ab (Dako, Glostrup, Denmark). They were used for further 
experiments right away or after 6-120 h of culture (10-20  x  106 
EC in 100-mm petri dishes (model 3003; Falcon  Labware,  Oxnard, 
CA) in 10 ml culture medium (RPMI 1640 supplemented with 
10% FCS [56~  0.5 h; Seromed, Biochrom KG, Berlin, Germany  1, 
1 mM t-glutamine, 5 x  10 -s M 2-ME, and 50/~g/ml gentamycin 
sulfate). 0.5-96 h before the end of culture we usually removed 
the nonadherent cells and added fresh medium with or without 
LPS (1 #g/ml) plus PMA (5 ng/ml).  At the end of culture the 
supernatants and/or adherent cells were harvested and processed 
for detection of IL-7  protein and mRNA, respectively.  Besides  mu- 
fine keratinocytes,  we also examined  the widely used spontaneously 
transformed BALB/c keratinocyte cell line PAM 212. 
Preparation of  Human Epidermal Cells and Keratinocytes.  Normal 
human, female  breast skin was obtained from corrective  plastic sur- 
gery. To obtain single EC suspensions split-thickness skin was ex- 
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Scotland) in PBS as described previously (17). In most experiments, 
EC were then treated with anti-HLA-DR/DQ mAb (clone 9.3F10, 
kindly provided by Dr. R. M. Steinman, The Rockefeller Univer- 
sity, New York), anti-CD3 (Becton Dickinson & Co., Mountain 
View, CA) and rabbit C' to remove epidermal Langerhans and T 
ceils. 15-20  x  106 EC were then plated in 10 ml culture medium 
in 100-mm petri dishes that had been coated with human collagen 
type IV (Collaborative Research Inc., Bedford, MA) to increase 
plating efficiency, and cultured for up to 40 d. Alternatively, we 
cultured EC on 3T3 feeder exactly as described (18), and used them 
for our experiments as secondary cultures which consisted almost 
exclusively of keratinocytes (18). Human (subconfluent to confluent) 
cultures were processed like murine ones (see above). Results ob- 
tained with primary cultures of freshly isolated  EC fractions and 
secondary 3T3 feeder layer EC cultures were identical. 
Preparation of Epidermal Sheets.  Epidermal sheets  were peeled 
from the epidermis either after short-term incubation in dispase 
type II (Boehringer-Mannbeim, Mannheim, FRG) (19) or after heat 
exposure (55~  for '~30 s). 
Preparation of RNA and cDNA.  Total cellular  RNA was iso- 
lated by the guanidinium isothiocyanate/cesium chloride method 
as described (16), and poly(A)  § RNA by using the mRNA isola- 
tion kit (Stratagene Cloning Systems,  La Jolla, CA).  For PCR, 
5 #g of total cellular RNA was reverse transcribed using a cDNA 
cycle kit (Invitrogen, San Diego, CA) as described  (14). 
Detection of  lL  7 mRNA by RT-PCR.  PCR conditions (30 cycles) 
were exactly as described (14). PCR primer pairs were purchased 
from  Clontech  (Palo  Alto,  CA)  except for keratin  (5'  primer: 
AGGCAGCGGCCCACTGAGATC-Y;  3'  primer:  5'-CATCTC- 
CACATTGACGTCTCC-Y; amplified fragment: 360 bp). Primers 
for murine IL-7 were: 5' primer: 5'-GCCTGTCACATCATCTGA- 
GTGCC-Y; 3' primer: 5'-CAGGAGGCATCCAGGAACTTCTCr3'; 
amplified fragment: 496 bp. Primers for human IL-7  were: 5' primer: 
5'-ATGTTCCATGTTTCTTTTAGGTATATCT-Y; 3' primer:  5'- 
TGCATTTCTCAAATGCCCTAATCCG-Y; amplified fragment: 
681 bp.  PCR reaction products were separated  as described (14) 
at 60 V for 2 h in 1% agarose in lx  TBE buffer containing 0.5 
ttg/ml ethidium bromide. 1/xg of a 1-kb and a 123-bp DNA ladder 
(Gibco BILL, Gaithersburg, MD) were run in parallel as molecular 
weight markers.  The specificity of the amplified bands was vali- 
dated by their predicted size and restriction enzyme digests giving 
appropriately sized fragments. Negative controls were included with 
each experiment (no cDNA, no cDNA but primers added; no RT, 
RNA reverse transcribed in the absence of reverse transcriptase). 
Detection of lL7 mRNA by Northern Blotting.  To confirm the 
results  obtained  by  PCR  we  performed Northern  blotting  as 
described (14) (20/zg  total cytoplasmic RNA  or 6  /zg mRNA 
per  lane)  using  a  routine  I1.-7 cDNA  probe  (2)  labeled  with 
c~-[s2P]dATP (Amersham  International,  Amersham,  UK)  using 
the oligoprimer procedure. 
Detection of lb7 mRNA by In Situ Hybridization.  Human and 
murine keratinocytes grown on glass coverslips and 7-/~m cryosec- 
tions of normal and diseased (atopic dermatitis) human skin were 
investigated using digoxigenin-labded probes and an in situ detec- 
tion kit essentially according to the manufacturer (British Biotech- 
nology Products Ltd., Abigdon, Oxon, UK). Probes used to de- 
tect Ib7 mRNA, and (as a positive control) Iblc~ and actin mRNA 
consisted each of a cocktail of three exon-specific antisense  oligo- 
nucleotides of '~30 bases in length to maximize sensitivity.  The 
IL-7 probes were tested by dot-blot hybridization technique using 
murine and human IL-7 cDNAs (2, 20). As a negative control probe 
we used a digoxigenin-labeled synthetic 30-met oligonucleotide 
(GGCGACGCGCCGTATTTATAATTCATTATG)  that has a low 
homology to known cDNAs and the same GC content (48%) and 
melting  temperature  (86~  as  the  other  probes  used.  Bound 
digoxigenin-labeled  probes were visualized according to the manu- 
facturer's instructions using an antidigoxigenin Fab fragment con- 
jugated  to alkaline  phosphatase and  5-bromo-4-chloro-3-indoyl- 
phosphate  (BCIP)  as  a  substrate,  which  yields  a  purple/black 
precipitate. 
Detection oflL7 Protein.  Supernatants of keratinocyte cultures 
were used right away, or were lyophilized and reconstituted in 20% 
of the original volume. Supernatants were tested using a cell line 
(IxN/2bx) that proliferates  in response  to IL-7 but neither to any 
other cytokine nor to LPS or PMA (detection limit  '~5 pg/ml) 
(10; Namen, A. E., unpublished results). The Ib7 content of human 
keratinocyte supernatants was also measured using a commercially 
available ELISA (British Biotechnology Products Ltd.; detection 
limit 4.5 pg/ml) that uses a neutralizing mAb to capture biologi- 
call), active Ib7. 
Results and Discussion 
Murine  and Human  Keratinocytes Express IL-7  mRNA  In 
Vitro,  Freshly isolated murine BALB/c EC (Fig.  1) as well 
as EC that had been depleted of epidermal Langerhans cells 
and TCR-3,/t5 bearing dendritic epidermal T  cells (data not 
shown) and constituted virtually pure keratinocytes (see Ma- 
terial and Methods),  expressed IL-7 mlLNA,  although  not 
invariably,  as demonstrated by ILT-PCR.  When  examined 
after 6, 12, 24, 36, or 48 h of culture (with or without stim- 
ulation with LPS [1 #g/ml],  PMA [5 ng/ml],  or LPS plus 
Figure  1.  PCR analysis of cytokine gene expression  by unffactionated 
EC suspensions prepared from murine ear skin by trypsinization (see 
Materials and Methods). Lanes 1-14: 1-kb DNA ladder, Iblc~,  IL-1B, 
Ib2, IL-3,  IL-4, Ib5, Ib6, IL-7,  TNF-cr TNF-/~, GM-CSF, IFNt~, 123-bp 
DNA ladder. Results obtained with two EC samples (tl and B) are shown 
to demonstrate the usual variability of cytokine mRNA expression we 
observed. Note that bands specific  for IL-7 (lane 9) and GM-CSF (lane 
I2) are present in A, but absent in B. lb6 mRNA is detectable only in 
sample B. Both EC suspensions  yield  bands specific  for II:1cr mRNA (lane 
2) (which is produced by keratinocytes  [14] but not Langerhans  cells), Ib 
1~ (which is produced  by Langerhans  cells  but not keratinocytes  [14]) (faint 
hands in lane 2), TNF-a (lane I0), and TNF-B (lane 1I). 
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tured murine keratinocytes (A) (cultured for 6 h, lanes 2 and 3; cultured 
for 24 h with LPS/PMA, lane 4; without stimulation,  lanes 5-9) and the 
keratinocyte  cell line PAM 212 (/3). Lane I,  1-kb DNA ladder;  lane 2, 
no RT control (see Material and Methods); lanes 3-5, II:7; lane 6, TNF-oq 
lane 7, IL-1B;  lane 8, TNF-c~; lane 9, TNF-/J; lane 10, 1-kb DNA ladder; 
lane  II-13, 1I.-7, lane 14, no RT control. 
for the last 0.5-24 h) keratinocytes uniformly expressed IL- 
7-spedfic bands (see  Fig. 2 A). The specificity  of the amplified 
bands was validated by their predicted size  and by restriction 
enzyme digests giving appropriately  sized fragments  (Fig. 
3 A). Northern blot analysis  confirmed that murine keratino- 
cytes express IL-7 mRNA (Fig. 4). Interestingly, IL-7 mRNA 
did not appear to be upregulated by LPS/PMA stimulation, 
although the release of IL-7 protein rose sharply (see  below, 
and Table 1). We also used in situ hybridization, which yielded 
only a barely detectable or no signal at all (data not shown). 
Figure  3.  (A) Restriction enzyme analysis of  amplified DNA fragments 
generated from reverse transcriptase PCP, of murine keratinocyte RNA 
verifies the specificity for IL-7. Lane 1, 1-kb DNA ladder; lane 2, uncut; 
lane 3, EcoRl digestion Odd& 236- and 233-bp fragments); lane 4, DdeI 
digestion  (yields 341- and 140-bp fragments,  and a 15-bp fragment not 
included on the gel); lane 5, Sau3AI digestion (yields a 430-bp fragment 
and a barely visible 66-bp fragment);  lane 6, uncut; lane 7, 100-bp DNA 
ladder. (/3) PCR analysis demonstrates IL-7  mRNA expression in cultured 
human keratinocytes. Lane I, 123-bp DNA ladder; lanes 2 and 3, LL-7; 
lane 4, no cDNA control; lane 5, Bz-microglobulin; lane 6, no ILT con- 
trol.  The specificity of the IL-7  amplified fragments was validated by re- 
striction  enzyme digestion  with TaqI and Apyl (data not shown). 
Figure  4.  Northern blot analysis 
of Ib-7 mRNA expression in murine 
keratinocytes.  6  /~g  of  poly(A) + 
RNA  derived  from  16-h cultured 
subconfluent  keratinocytes  (1,  un- 
stimulated,  2, stimulated  by LPS [1 
#g/ml] plus PMA [5 ng/ml] for 4 h) 
was  hybridized  with  a  32p-labeled 
IL-7  cDNA probe (1-d film exposure). 
(Horizontal bars) 18 and 28S rRNA. 
Table  1.  IL-7 Bioactivity of Conditioned Media from Murine Epidermal Keratinocyte Cultures 
Keratinocyte  culture: 
Expt.  Period  of medium  conditioning  Stimulation  IL-7 bioactivity 
Day 2  subconfluent  -~  day 3  confluent 
Day 2  subconfluent  "~  day 3  confluent 
Day 2  subconfluent  "*  day 3  confluent 
LC and T  cell depleted 
Day 2  subconfluent  ~  day 3  confluent 
LC  and  T  cell depleted 
Day 0,  fresh  cells  "*  day  1  subconfluent 
LC  and  T  cell depleted 
Day  1  subconfluent  -~  day 2  subconfluent 
LC  and T  cell depleted 
Day 0,  fresh  cells  "~  day 3  confluent 
Day 0,  fresh  cells  ~  day 2  confluent 
pg/ml 
None  12 
LPS plus  PMA  192 
None  10 
LPS plus  PMA  96 
None  5 
None  24 
None  24 
None  48 
Bioactivity was assayed by measuring the proliferation  of the IL-7-dependent indicator cell line IxN/2bx. This cell line neither responds to any known 
cytokine nor to LPS or PMA (13; Namen, A.E.,  unpublished  observations).  Culture supernatants  were added to the indicator  cells in a series of 
twofold dilutions.  Bioactivity  in pg/ml was calculated from a standard  curve established with human recombinant  IL-7.  LPS was used at  a final 
concentration of 1/zg/ml;  PMA at 5 ng/ml. 
1111  Heufler  et al.  Brief Definitive  Report Figure 5.  PCR analysis  ofcytokine gene expression by murine epidermal 
sheets prepared by heat separation (550C for about 30 s) alone. Lanes 1-14 
(top):  1-kb DNA  ladder,  Iblot, IL-I~, 11,2, I1,3,  I1,4,  I1,5, I1,6, I1,7, 
TNP-ot,  TNF-/3,  GM-CSF,  IFN-ot,  123-bp  DNA  ladder;  Lanes  1-14 
(bottom):  1-kb DNA ladder, IFN-/~, IFN-% I1,2R, TGF-B, CD4, CD8, 
/~2-microglobulin, macrophage inflammatory protein (MIP)  lot, MIP-1B, 
MIP-2, B-actin, keratin, 123-bp DNA ladder. Note that cytokine mRNAs 
are not readily detectable although B2-microglobulin  (lane 8) and keratin 
(lane  13)  mRNAs are. 
The in situ hybridization experiments were, however, neverthe- 
less  useful  in  that  they  excluded  that  only  a  minor con- 
taminating cell population strongly expressed IL-7 mKNA, 
thus mimicking IL-7 mRNA expression by the keratinocytes. 
Our finding that the BALB/c-derived keratinocyte line PAM 
212 also produces IL-7 mRNA (Fig. 2 B, lanes 11-13)  fur- 
ther underscored that murine keratinocytes can indeed tran- 
scribe IL-7 mRNA.  Studying human keratinocyte cultures 
by KT-PCK analysis revealed that human keratinocytes, just 
like murine ones, constitutively express IL-7 mRNA in vitro 
(Fig.  3/3). 
Murine  and Human  Keratinocytes Release  IL-2  Protein  In 
Vitra  In  pilot  experiments  employing  the  IL-7-induced 
proliferation of pre-B cells grown in Whitlock-Witte bone 
marrow cultures as an IL-7 bioassay system (1), putative IL-7 
activity (i.e., proliferation of pre-B ceils that could be blocked 
by anti-IL-7 mAb) was detected only in one out of seven su- 
pernatants of stimulated (LPS plus PMA) murine keratino- 
cytes, and not at all in supernatants from unstimulated ker- 
atinocytes (data not shown).  Using an IL-7-dependent cell 
line that is more sensitive to IL-7 and responds neither to 
any other known cytokine nor to LPS and PMA (10; Namen, 
A. E., unpublished results), we could usually detect IL-7 in 
supernatants,  particularly  after  stimulation  of murine ker- 
atinocytes with LPS and PMA (Table 1). We could not un- 
equivocally demonstrate IL-7 activity in human keratinocyte 
supernatants by using the IL-7-dependent cell line, yet were 
able to detect low amounts oflL-7 protein by an ELISA assay 
(Table 2). The fact that keratinocytes release only little IL-7 
protein does not mean that their production of IL-7 is bio- 
logically irrelevant, as all the cells and cell lines that have been 
found to produce IL-7 do so only at low levels.  The case is 
the most extreme in the human cell lines as it was even difhcuh 
to detect IL-7 production by the SK-Hep cell line (Namen, 
A.  E.,  unpublished results),  which was used  to done  the 
cDNA  for the human IL-7 (20). 
11.-7 mRNA  Is Expressed  in Diseased Murine and Human 
Epidermis.  To get information as to whether IL-7 mRNA 
is constitutively expressed in murine epidermis in situ, we 
studied epidermal sheets that had been prepared by heat sepa- 
ration (55~  for 30 s) rather than by conventional methods 
that require prolonged incubation (e.g., in dispase). We usu- 
ally did not detect cytokine mRNAs by PCR analysis,  al- 
though  control  B2-microglobulin mRNA  was  readily  de- 
Table  2.  IL-7 Immunoactivity of Conditioned Media from Human Epidermal Keratinocyte Cultures as Determined by ELISA 
IL-7 secreted into  the  culture  medium 
Experiment  Day 0  3  4  5  6  7  8  9  10  13  36-40 
1 
2 
3 
4 
5 
6* 
￿9  nd 
￿9  nd 
i,  nd 
--  1.1 
pg/ml 
2.7  ￿9  7.1 
2.2  P  6.0  =  7.8  23.0 
1.1 
6.0 
￿9  16.0  ~  13.0 
4.2 
Culture supernatants were collected at the different time points, concentrated five times, and assayed by means  of a commercial ELISA kit. The 
standard curve was established  using recombinant human IL-7. Note that the amount of immunoreactive IL-7 increases with the time in culture. 
* Secondary keratinocyte cultures obtained by the 3T3 feeder layer technique (see Materials and Methods); supernatants of 3T3 cells were consis- 
tently negative. 
nd,  not detectable. 
1112  I1,7  Is Produced by Murine and Human Keratinocytes tectable  (Fig.  5).  The  expression  of  IL-7  mKNA  by 
keratinocytes after their isolation from the skin is thus likely 
induced relative to the normal epidermis in situ (compare 
Figs.  1 and 5).  In the course of allergic contact dermatitis 
(elicited  by  haptens  like  dinitrochlorobenzene),  however, 
IL-7  mKNA  is  expressed  in  murine  epidermis  (data  not 
shown), presumably by keratinocytes.  Similarly, we found 
IL-7 mKNA in the epidermis of human diseased skin (e.g., 
atopic dermatitis), whereas IL-7 mRNA was often not readily 
detectable in nonlesional skin (data not shown). So far, we 
have not been able to unequivocally detect IL-7 mRNA by 
in situ hybridization in such diseased epidermis, although IL-7 
mRNA was clearly present in rare stellate cells in the retic- 
ular dermis (data not shown). 
Possible Relevance of Keratinocyte-derived IL-Z  The range 
of cell types that express IL-7 mKNA and produce IL-7 is 
not yet well established. Previous studies have, for example, 
shown that spleen and thymus cells express IL-7 mRNA, 
although biologically active IL-7 could not be detected in 
respective supernatants (2).  Our finding that keratinocytes 
can express IL-7 mKNA and release IL-7 in biologically rele- 
vant amounts is, therefore, certainly noteworthy. The physi- 
ological relevance of our finding escapes us at present, partic- 
ularly as little or no IL-7 mKNA seems to be present in the 
adult, normal epidermis under steady-state conditions. One 
interesting possibility, at least in murine epidermis, is that 
keratinocyte-derived IL-7 acts on epidermal T cells. We have 
observed that highly enriched TCR-3,/8 bearing murine den- 
dritic epidermal T cells exhibit a modest proliferative response, 
although not invariably, in response to IL-7 (with or without 
Con A, PHA, or PMA added) (Elbe, A., E. Payer, G. Schuler, 
and G.  Stingl, unpublished observations).  Furthermore,  it 
has recently been demonstrated that IL-7 can induce TCK-'y 
gene expression by pre-T cells (21) in fetal liver and that TCK- 
3'//$  expressing  dendritic  epidermal T  cells  develop from 
Thyl+,  CD3-,  TCK-  precursors in fetal skin (22).  It is 
thus conceivable that IL-7 is constitutively expressed in vivo 
by normal murine keratinocytes at certain stages during on- 
togeny and critical to the development of TCK-3'/~ bearing 
T cells in murine epidermis. To get further hints as to a poten- 
tial physiological role of keratinocyte-derived IL-7 it will, of 
course, be interesting to study whether other epidermal sym- 
bionts such as Langerhans cells or cells in the dermis respond 
to IL-7. Our finding that IL-7 mKNA is expressed in dis- 
eased epidermis (probably by keratinocytes) raises the issue 
of a potential role of IL-7 in skin diseases. The observation 
that IL-7 has costimulatory activity on purified mature T 
cells and is a T cell growth factor for in vivo primed antigen- 
specific T cells (4-8) suggests that keratinocyte-derived IL-7 
might be pathogenetically significant in a variety of inflam- 
matory cutaneous diseases.  IL-7 might, however, also be an 
important progression factor in cutaneous T cell lymphoma 
as it has been shown to be a growth factor for various lym- 
phoma cells, including those of cutaneous T cell lymphoma 
(10-13).  One might even hypothesize that keratinocyte-derived 
IL-7 is relevant for the generation of cutaneous T  cell lym- 
phomas. Remarkably, cutaneous lymphoprolifcration and lym- 
phomas have recently been described in IL-7 transgenic mice 
(23). 
The finding that keratinocytes can produce IL-7 raises sev- 
eral interesting issues for further studies on the biology and 
pathology of skin. Our studies also demonstrate that cytokine 
mRNAs are upregulated during enzyme digestion procedures 
usually employed to prepare epidermal cells.  This observa- 
tion underscores the importance of considering alternative 
techniques such as heat separation for preparing epidermal 
sheets for RNA preparation or in situ hybridization to ob- 
tain information that is truly relevant for the in vivo situation. 
We thank Drs.  Christian Peschel and Diane Young for performing the IL-7 bioassay using pre-B cells. 
This work was supported by the Austrian Science Foundation (FWF grant P 8549M to G. Schuler). 
Address correspondence to Dr. Gerold Schuler, Department of Dermatology, University of Innsbruck, 
Anichstr.  35, A-6020 Innsbruck, Austria. 
Received for publication 17 March 1993 and in revised  form 3June 1993. 
ReFerences 
1.  Namen, A.E., A.E. Schmierer, C.J. March, K.W. Overell, L.S. 
Park, D.L. Urdal, and D.Y. Mochizuki. 1988. B cell precursor 
growth-promoting activity. Purification and characterization 
of a growth factor active on lymphocyte precursors. J. Extx 
Med. 167:988. 
2.  Namen,  A.E.,  S.  Lupton,  K.  Hjerrild,  J.  Wignall,  D.Y. 
Mochizuki, A. Schmierer, B. Mosley, C.J. March, D. Urdal, 
S. Gillis, et al. 1988. Stimulation of B-cell progenitors by cloned 
murine interleukin-7. Nature (Lond.). 333:571. 
3.  Carding, S.K., A.C. Hayday, and K. Bottomly. 1991. Cytokines 
in T-cell development. Immunol. Today. 12:239. 
4.  Morrissey, P.J., K.G. Goodwin, K.P. Nordan, D. Anderson, 
K.H. Grabstein, D. Cosman, J. Sims, S. Lupton, B. Acres, S.G. 
Reed, et al. 1989. Recombinant interleukin 7, pre-B cell growth 
factor, has costimulatory activity on purified mature T cells. 
J. Exl~ ivied. 169:707. 
5.  Chazen, G.D., G.M.B. Pereira, G. LeGros, S. Gillis, and E.M. 
Shevach. 1989. Interleukin 7 is a T-cell growth factor. Prog 
1113  Heufler  et al.  Brief  Definitive Report Natl. A_cad. Sci. USA.  86:5923. 
6.  Welch, P.A., A.E. Namen, K.G. Goodwin, R. Armitage, and 
M.D. Cooper. 1989. Human IL-7: a novel T cell growth factor. 
J. Immunol.  143:3562. 
7.  Londei, M., A. Verhoef,  C. Hawrylowicz, J. Groves, P. De 
Berardinis,  and M. Feldmann. 1990. Interleukin 7 is a growth 
factor for mature human T  cells. Eur. j.  Immunol.  20:425. 
8.  Grabstein,  K.H., A.E. Namen, K. Shanebeck, K.F. Voice, S.G. 
Reed, and M.B. Widmer. 1990. Regulation ofT cell prolifera- 
tion by IL-7.  j.  Immunol.  144:3015. 
9.  Heufler, C., D. Young, C. Peschel, and G. Schuler. 1990. Mu- 
fine keratinocytes express  interleukin-7. J.  Invest. Dermatol. 
94:534.  (Abstr.) 
10.  Park, L.S., D.J. Friend, A.E. Schmierer, S.K. Dower, and A.E. 
Namen.  1990. Murine interleukin 7 (II~7) receptor. Charac- 
terization of an IL-7-dependent cell line.J. Exl~ Med. 171:1073. 
11.  Digel, W., M. Schmid, G. Heil, P. Conrad, S. Gillis, and F. 
Porzsolt. 1991. Human interleukin-7 induces proliferation of 
neoplastic cells from chronic lymphocytic leukemia and acute 
leukemias.  Blood. 78:753. 
12.  Dibirdik, I., M.-C. Langlie, J.A. Ledbetter, L. Tuel-Ahlgren, 
V. Obuz, K.G. Waddick, K. Gajl-Peczalska,  G.L. Schieven, 
and F.M. Uckun. 1991. Engagement ofinterleukin-7 receptor 
stimulates tyrosine phosphorylation, phosphoinositide turn- 
over, and clonal proliferation of human T-lineage acute lym- 
phoblastic leukemia cells. Blood. 78:564. 
13.  Dalloul, A., L. Laroche, M. Bagot, M.D. Mossalayi, C. Four- 
cade, D.J.  Thacker, D.E. Hogge, H. Merle-B~ral,  P. Debr~, 
and C. Schmitt. 1992. Interleukin-7 is a growth factor for S~zary 
lymphoma cells. J.  Clin.  Invest. 90:1054. 
14.  Heufler, C., G. Topar, F. Koch, B. Trockenbacher, E. I4dimpgen, 
N. Komani, and G. Schuler. 1992. Cytokine gene expression 
in murine epidermal cell suspensions: interleukin 1 B and mac- 
rophage inflammatory protein lc~ are selectively expressed in 
Langerhans cells but are differentially regulated in culture. J. 
Ext~ Med.  176:1221. 
15.  Stingl, G., K.C. Gunter, E. Tschachler, H. Yamada, K.I. Lechler, 
W.M. Yokoyama, G. Steiner, K.N. Germain, and E.M. Shevach. 
1987.  Thy-1 + dendritic epidermal cells belong to the T-cell 
lineage.  Proa Natl. Acad. Sci. USA.  84:2430. 
16.  Koch, F., C. Heufler, E. K~mpgen, D. Schneeweiss, G. Brck, 
and G. Schuler. 1990. Tumor necrosis factor ot maintains the 
viability of murine epidermal Langerhans cells in culture but 
in  contrast  to  granulocyte/macrophage colony-stimulating 
factor without inducing their functional maturation. J. Exp. 
Med.  171:159. 
17.  Romani, N., A. Lenz, H. Glassel, H. Strssel, U. Stanzl, O. 
Majdic, P. Fritsch, and G. Schuler. 1989. Cultured human Lan- 
gerhans cells resemble lymphoid dendritic cells in phenotype 
and function, j.  Invest. Dermatol. 93:600. 
18.  Niederwieser, D., J.  Aubrck, J.  Troppmair, M.  Herold, G. 
Schuler, G. Brck, J. Lotz, P. Fritsch, and C. Huber. 1988. IFN- 
mediated induction of MHC antigen expression on human ker- 
atinocytes and its influence on in vitro alloimmune responses. 
J. Immunol.  140:2556. 
19.  Kitano, Y., and N. Okado. 1983. Separation of the epidermal 
sheet by dispase. Br. j.  Dermatol.  108:555. 
20.  Goodwin, R.G., S. Lupton, A. Schmierer,  K.J. Hjerrild, K. 
Jerzy, W. Clevenger, S. Gillis, D. Cosman, and A.E. Namen. 
1989.  Human interleukin 7: molecular cloning and growth 
factor activity on human and murine B-lineage cells. Proc. Natl. 
Acad. Sci. USA.  86:302. 
21.  Appasamy,  P.M.  1992.  IL 7-induced T  cell receptor-gamma 
gene expression by pre-T cells in murine fetal liver cultures. 
j.  Immunol.  149:1649. 
22.  Elbe, A., O.  Kilgus,  R. Strohal, E. Payer, S. Schreiber,  and 
G. Stingl. 1992. Fetal skin: a site of dendritic epidermal T cell 
development. J. Immunol.  149:1694. 
23.  Kich, B.E., J. Campos-Torres,  K.I. Tepper, R.W. Moreadith, 
and P. Leder. 1993. Cutaneous lymphoproliferation and lym- 
phomas in interleukin 7 transgenic mice.J. Exl~ Med. 177:305. 
1114  Ib7 Is Produced by Murine and Human Keratinocytes 